Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Marcon

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vaccine|March 10, 2005
HIV vaccine development by computer assisted design: the GAIA vaccineAnne S De Groot, Luisa Marcon, Elizabeth A Bishop, et al.
Vaccine|March 10, 2005
Developing an epitope-driven tuberculosis (TB) vaccineAnne S De Groot, Julie McMurry, Luisa Marcon, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|March 6, 2004
HIV fitness and resistance as covariates associated with the appearance of mutations under antiretroviral treatmentCarlo Federico Perno, Alessandra Cenci, Cristina Piro, et al.
The Journal of Antimicrobial Chemotherapy|April 23, 2005
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophagesStefano Aquaro, Valentina Svicher, Francesca Ceccherini-Silberstein, et al.
Methods (San Diego, Calif.)|November 16, 2004
Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccineAnne S De Groot, Elizabeth A Bishop, Basim Khan, et al.
AIDS (London, England)|July 29, 2004
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressureFrancesca Ceccherini-Silberstein, Fulvio Erba, Federico Gago, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vaccine|March 10, 2005
HIV vaccine development by computer assisted design: the GAIA vaccineAnne S De Groot, Luisa Marcon, Elizabeth A Bishop, et al.
Vaccine|March 10, 2005
Developing an epitope-driven tuberculosis (TB) vaccineAnne S De Groot, Julie McMurry, Luisa Marcon, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|March 6, 2004
HIV fitness and resistance as covariates associated with the appearance of mutations under antiretroviral treatmentCarlo Federico Perno, Alessandra Cenci, Cristina Piro, et al.
The Journal of Antimicrobial Chemotherapy|April 23, 2005
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophagesStefano Aquaro, Valentina Svicher, Francesca Ceccherini-Silberstein, et al.
Methods (San Diego, Calif.)|November 16, 2004
Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccineAnne S De Groot, Elizabeth A Bishop, Basim Khan, et al.
AIDS (London, England)|July 29, 2004
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressureFrancesca Ceccherini-Silberstein, Fulvio Erba, Federico Gago, et al.
Pageof 1